Obese diabetics
Clinical trials for Obese diabetics explained in plain language.
Never miss a new study
Get alerted when new Obese diabetics trials appear
Sign up with your email to follow new studies for Obese diabetics, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Three blockbuster Weight-Loss drugs go Head-to-Head in diabetic and Non-Diabetic adults
Disease control CompletedResearchers compare three weekly GLP-1 receptor agonists, dulaglutide, semaglutide, and tirzepatide, in 159 obese adults, 84 with diabetes and 75 without. Participants receive one of the drugs for 24 weeks. The trial measures changes in body weight, BMI, blood sugar, cholesterol,…
Matched conditions: OBESE DIABETICS
Phase 3 • Sponsor: Zagazig University • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Diabetes drug study reveals hidden genetic links to weight and inflammation
Disease control CompletedThis completed study looked at how two common diabetes drugs, dapagliflozin and empagliflozin, affect weight, cholesterol, and inflammation in 260 obese adults newly diagnosed with type 2 diabetes. Over six months, researchers measured changes in body weight, blood fats, and mark…
Matched conditions: OBESE DIABETICS
Phase 4 • Sponsor: Erbil Polytechnic University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC